These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Perceptual gap between oncologists/oncology nurses and patients in the management and impact of chemotherapy/radiotherapy-induced nausea and vomiting: French results of the GAP survey]. Morin S; Leurs I; Bousquet MN; Scotté F Bull Cancer; 2016 May; 103(5):469-77. PubMed ID: 27015797 [TBL] [Abstract][Full Text] [Related]
26. Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot study. Dullemond-Westland AC; Neijt JP; Nortier JW; Sitsen JM Radiother Oncol; 1986 Jun; 6(2):127-33. PubMed ID: 3526421 [TBL] [Abstract][Full Text] [Related]
27. Antiemetic prophylaxis of cancer chemotherapy-induced nausea and vomiting with cinnarizine and lorazepam. Wilder-Smith CH; Senn HJ Oncology; 1989; 46(3):169-72. PubMed ID: 2717127 [TBL] [Abstract][Full Text] [Related]
28. [1 year's use of alizapride for the prevention and treatment of nausea and vomiting secondary to anticancer agents]. Olivier JP Ann Gastroenterol Hepatol (Paris); 1985 Jan; 21(1):53-5. PubMed ID: 3977279 [No Abstract] [Full Text] [Related]
29. Phase I-trial of clebopride, a new antiemetic, in chemotherapy--induced nausea and vomiting. Lenz HJ; Schuler U; Hicking W; Ehninger G Eur J Clin Pharmacol; 1990; 38(5):525. PubMed ID: 2379541 [No Abstract] [Full Text] [Related]
30. [New aspects in the prevention and therapy of cytostatic drug-induced nausea and vomiting]. Evers C; Riess H Z Arztl Fortbild (Jena); 1992 Sep; 86(17):847-53. PubMed ID: 1413901 [No Abstract] [Full Text] [Related]
31. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients. Levitt M Cancer Treat Rev; 1982 Dec; 9 Suppl B():49-53. PubMed ID: 6299556 [No Abstract] [Full Text] [Related]
34. The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control. Sagar SM Cancer Treat Rev; 1991 Jun; 18(2):95-135. PubMed ID: 1804527 [No Abstract] [Full Text] [Related]
35. [Anti-emetic effect of granisetron in patients undergoing cranial and craniospinal radiotherapy]. Yamasaki F; Watanabe Y; Nosaka R; Kenjo M; Nakamura K; Takayasu T; Saito T; Tominaga A; Sugiyama K; Kurisu K No Shinkei Geka; 2014 Jan; 42(1):27-34. PubMed ID: 24388937 [TBL] [Abstract][Full Text] [Related]
36. Multinational Association of Supportive Cancer Care (MASCC). Roila F; Support Care Cancer; 2003 Apr; 11(4):260-1. PubMed ID: 12749339 [No Abstract] [Full Text] [Related]
37. [Nausea and vomiting induced by anticancer chemotherapy: mechanisms and prevention]. Bonneterre J; Adenis L Pathol Biol (Paris); 1989 Feb; 37(2):163-4. PubMed ID: 2652072 [No Abstract] [Full Text] [Related]
38. Improving Adherence to Evidence-Based Guidelines for Chemotherapy-Induced Nausea and Vomiting. Wood M; Hall L; Hockenberry M; Borinstein S J Pediatr Oncol Nurs; 2015; 32(4):195-200. PubMed ID: 25576315 [TBL] [Abstract][Full Text] [Related]
39. Synthetic marijuana for nausea and vomiting due to cancer chemotherapy. Med Lett Drugs Ther; 1985 Nov; 27(701):97-8. PubMed ID: 2999571 [No Abstract] [Full Text] [Related]
40. [Antiemetic effect of domperidone (R 33 812) in children undergoing cytotoxic therapy]. Chantraine JM; Reginster-Bous M Rev Med Liege; 1979 Mar; 34(6):199-202. PubMed ID: 441597 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]